Efficacy and Durability of Cognitive Behavior Therapy in Managing Hallucination in Patients with Schizophrenia

Overview

Journal Ind Psychiatry J

Date 2022 Jan 12

PMID 35017809

Authors

Priyanka Shukla

Debasish Padhi

K S Sengar

Abha Singh

Suprakash Chaudhury

Affiliations

Soon will be listed here.

Abstract

Background: The cognitive behavior therapy (CBT) approach to psychosis is a relatively recent development and focuses directly on the core psychotic symptoms of hallucinations and delusions.

Aim: The aim of this study is to assess the efficacy of cognitive behavior therapy in managing hallucination in patients with schizophrenia and to evaluate the generalizability and durability of the therapeutic gains.

Materials And Methods: In this confirmatory pre-post assessment study, based on the purposive sampling technique, a sample consisting of 40 (20 for experimental and the other 20 for control group) patients having schizophrenia with core symptoms of hallucination and delusions under treatment as usual were selected and matched on the sociodemographic and clinical variables. For the clinical variables, the Psychotic Symptom Rating Scale and Scale for the Assessment of Positive Symptoms were used. After baseline assessment, the cognitive behavioral program was tailored on the experimental group and patients of both the group were reassessed after the completion of treatment. Follow-up data to see the durability of program were taken from all the patients of experimental and control groups.

Results: Cognitive behavior therapy was found to be effective for the treatment of auditory hallucination in schizophrenia. The therapeutic gains in all study variables were found to be maintained or further improving at follow-up which proves that cognitive behavior therapy is durable.

Conclusion: Cognitive behavior therapy in conjunction with pharmacotherapy was found to be more effective in improving clinical symptoms of schizophrenia and global functioning compared to pharmacotherapy alone.

Citing Articles

Research on psychotherapy in India: A systematic review.

Selvapandiyan J, Das A, Singh G Indian J Psychiatry. 2024; 66(2):123-134.

PMID: 38523761 PMC: 10956596. DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_682_23.

Unsupervised Machine Learning Driven Analysis of Verbatims of Treatment-Resistant Schizophrenia Patients Having Followed Avatar Therapy.

Hudon A, Beaudoin M, Phraxayavong K, Potvin S, Dumais A J Pers Med. 2023; 13(5).

PMID: 37240971 PMC: 10223071. DOI: 10.3390/jpm13050801.

References

Chaudhury S . Hallucinations: Clinical aspects and management. Ind Psychiatry J. 2011; 19(1):5-12. PMC: 3105559. DOI: 10.4103/0972-6748.77625. View

Thomas N, Rossell S, Farhall J, Shawyer F, Castle D . Cognitive behavioural therapy for auditory hallucinations: effectiveness and predictors of outcome in a specialist clinic. Behav Cogn Psychother. 2010; 39(2):129-38. DOI: 10.1017/S1352465810000548. View

Propst A . The effects of cognitive therapy on hallucinations in patients with schizophrenia. Mcgill J Med. 2012; 13(1):55. PMC: 3277339. View

Mortan O, Tekinsav Sutcu S, German Kose G . [A pilot study on the effectiveness of a group-based cognitive-behavioral therapy program for coping with auditory hallucinations]. Turk Psikiyatri Derg. 2011; 22(1):26-34. View

Pontillo M, De Crescenzo F, Vicari S, Pucciarini M, Averna R, Santonastaso O . Cognitive behavioural therapy for auditory hallucinations in schizophrenia: A review. World J Psychiatry. 2016; 6(3):372-80. PMC: 5031939. DOI: 10.5498/wjp.v6.i3.372. View

Kumar S, Soren S, Chaudhury S . Hallucinations: Etiology and clinical implications. Ind Psychiatry J. 2010; 18(2):119-26. PMC: 2996210. DOI: 10.4103/0972-6748.62273. View

Turner D, Burger S, Smit F, Valmaggia L, van der Gaag M . What Constitutes Sufficient Evidence for Case Formulation-Driven CBT for Psychosis? Cumulative Meta-analysis of the Effect on Hallucinations and Delusions. Schizophr Bull. 2020; 46(5):1072-1085. PMC: 7505201. DOI: 10.1093/schbul/sbaa045. View

Wykes T, Steel C, Everitt B, Tarrier N . Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull. 2007; 34(3):523-37. PMC: 2632426. DOI: 10.1093/schbul/sbm114. View

Thomas N, Hayward M, Peters E, van der Gaag M, Bentall R, Jenner J . Psychological therapies for auditory hallucinations (voices): current status and key directions for future research. Schizophr Bull. 2014; 40 Suppl 4:S202-12. PMC: 4141318. DOI: 10.1093/schbul/sbu037. View

10.

Gottlieb J, Harper Romeo K, Penn D, Mueser K, Chiko B . Web-based cognitive-behavioral therapy for auditory hallucinations in persons with psychosis: a pilot study. Schizophr Res. 2013; 145(1-3):82-7. DOI: 10.1016/j.schres.2013.01.002. View

11.

Peters E, Crombie T, Agbedjro D, Johns L, Stahl D, Greenwood K . The long-term effectiveness of cognitive behavior therapy for psychosis within a routine psychological therapies service. Front Psychol. 2015; 6:1658. PMC: 4625031. DOI: 10.3389/fpsyg.2015.01658. View

12.

van der Gaag M, Valmaggia L, Smit F . The effects of individually tailored formulation-based cognitive behavioural therapy in auditory hallucinations and delusions: a meta-analysis. Schizophr Res. 2014; 156(1):30-7. DOI: 10.1016/j.schres.2014.03.016. View

13.

Lieberman J, Stroup T, McEvoy J, Swartz M, Rosenheck R, Perkins D . Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005; 353(12):1209-23. DOI: 10.1056/NEJMoa051688. View

14.

Burns A, Erickson D, Brenner C . Cognitive-behavioral therapy for medication-resistant psychosis: a meta-analytic review. Psychiatr Serv. 2014; 65(7):874-80. DOI: 10.1176/appi.ps.201300213. View

15.

Sommer I, Slotema C, Daskalakis Z, Derks E, Blom J, van der Gaag M . The treatment of hallucinations in schizophrenia spectrum disorders. Schizophr Bull. 2012; 38(4):704-14. PMC: 3577047. DOI: 10.1093/schbul/sbs034. View

16.

Nowak I, Sabariego C, Switaj P, Anczewska M . Disability and recovery in schizophrenia: a systematic review of cognitive behavioral therapy interventions. BMC Psychiatry. 2016; 16:228. PMC: 4940955. DOI: 10.1186/s12888-016-0912-8. View

17.

Haddock G, McCarron J, Tarrier N, Faragher E . Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med. 1999; 29(4):879-89. DOI: 10.1017/s0033291799008661. View

18.

Jauhar S, McKenna P, Radua J, Fung E, Salvador R, Laws K . Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. Br J Psychiatry. 2014; 204(1):20-9. DOI: 10.1192/bjp.bp.112.116285. View

19.

Zimmermann G, Favrod J, Trieu V, Pomini V . The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders: a meta-analysis. Schizophr Res. 2005; 77(1):1-9. DOI: 10.1016/j.schres.2005.02.018. View